Find the record
Documentation should be easy to locate.
The production model should support a searchable lot-document library with revision status, publish date and direct technical-support escalation.
Certificates of Analysis
Search by catalog number and lot, then review the release document and supporting data.
Storage & material notes
Product-specific handling, storage and transport information tied to the technical record.
RFQ preparation guide
Sequence, scale, modification, purity, analytics, presentation and required date.
Responsible-use FAQ
What does “research use only” mean in this model?
It describes materials intended for legitimate non-clinical laboratory investigation. It does not authorize administration to humans or animals, compounding, diagnosis, treatment or consumer use.
Are catalog records available for purchase?
Stocked research products display current pack options, availability and pricing on their product records. Bulk API and custom-synthesis requests use a qualification and written-quotation pathway.
How is bulk API supplied?
Bulk research API records describe Remetide-manufactured material beginning in 100 g increments. They are quotation-only: organization, intended use, specification, analytical package, packaging, destination, feasibility, lead time and applicable legal or intellectual-property review must be completed before an order can be accepted.
Can I submit a peptide sequence for design or synthesis?
The proposed workflow accepts a sequence or target concept, intended assay context, scale, target purity, modifications, format, analytics and timeline for technical review. Acceptance, feasibility, price and deliverables require a written project scope.
Can I request a peptide library or conjugate?
The proposed model includes libraries, labels, linkers, cyclization and conjugation concepts. The actual chemistry, library size, QC plan, yield and format must be confirmed before a project is accepted.
Does the model include small-molecule work?
Yes. A proposed small-molecule pathway accepts a structure, SMILES string, target concept or literature reference for route, safety, scale, purification and analytical review. It does not imply current in-house capacity or cGMP manufacture.
What documents should accompany a research material?
The proposed package may include a lot-specific COA, analytical summary, material specification and handling statement. Actual documents depend on the approved specification and project agreement.
How should purity be described?
Purity must identify the method and defer to the released lot result. Quality must approve molecule-specific criteria and public language.
Does Simple Life Science provide dosing or administration guidance?
No. The life-science model does not provide dosing, administration, medical advice or patient-specific guidance.
How are custom projects evaluated?
A technical review considers sequence, structure or item, intended laboratory context, scale, modifications, specification, analytics, presentation, timeline, safety, documentation and third-party rights.